Sernova (TSE:SVA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sernova Corp., a biotech company advancing cell therapies for chronic diseases, has announced the appointment of biotech veteran David Paterson Ph.D. to its Board of Directors. Paterson’s extensive experience in corporate development and his biopharma industry knowledge are expected to bolster Sernova’s growth and its innovative Cell Pouch System technology, particularly in the type 1 diabetes sector.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money